Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®

PHASE3CompletedINTERVENTIONAL
Enrollment

416

Participants

Timeline

Start Date

August 9, 2016

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
COPD
Interventions
DRUG

BGF MDI (PT010)

Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol, BGF MDI, PT010

DRUG

GFF MDI (PT003)

Glycopyrronium and Formoterol Fumarate Inhalation Aerosol, GFF MDI, PT003

DRUG

BFF MDI (PT009)

Budesonide and Formoterol Fumarate Inhalation Aerosol, BFF MDI, PT009

DRUG

Symbicort® Turbohaler® Inhalation Powder

Budesonide and Formoterol Fumarate Inhalation Powder, Symbicort® Turbohaler® Inhalation Powder, Symbicort Turbohaler

Trial Locations (79)

113-8431

Research Site, Bunkyō City

103-0022

Research Site, Chūōku

104-0031

Research Site, Chūōku

104-8560

Research Site, Chūōku

969-1793

Research Site, Date-gun

814-0180

Research Site, Fukuoka

901-2214

Research Site, Ginowan-shi

812-0033

Research Site, Hakata-shi

430-0906

Research Site, Hamamatsu

430-8525

Research Site, Hamamatsu

434-8511

Research Site, Hamamatsu

992-0601

Research Site, Higashiokitama-gun

577-0843

Research Site, Higashiosaka-shi

672-8064

Research Site, Himeji-shi

573-1191

Research Site, Hirakata-shi

820-8505

Research Site, Iizuka-shi

173-8610

Research Site, Itabashi-ku

438-8550

Research Site, Iwata-shi

693-0068

Research Site, Izumo-shi

693-8501

Research Site, Izumo-shi

892-0847

Research Site, Kagoshima

920-0293

Research Site, Kahoku-gun

675-0023

Research Site, Kakogawa-shi

714-0081

Research Site, Kasaoka-shi

816-0813

Research Site, Kasuga-shi

596-8501

Research Site, Kishiwada-shi

204-0023

Research Site, Kiyose-shi

650-0017

Research Site, Kobe

811-3195

Research Site, Koga-shi

711-0921

Research Site, Kurashiki-shi

737-0193

Research Site, Kure-shi

737-8505

Research Site, Kure-shi

601-1495

Research Site, Kyoto

601-8206

Research Site, Kyoto

602-8026

Research Site, Kyoto

607-8062

Research Site, Kyoto

615-8087

Research Site, Kyoto

371-0054

Research Site, Maebashi

390-0872

Research Site, Matsumoto-shi

515-0073

Research Site, Matsusaka-shi

153-8515

Research Site, Meguro-ku

181-8611

Research Site, Mitaka-shi

509-6134

Research Site, Mizunami-shi

940-2085

Research Site, Nagaoka-shi

454-8502

Research Site, Nagoya

457-8511

Research Site, Nagoya

466-8560

Research Site, Nagoya

902-0061

Research Site, Naha

969-0213

Research Site, Nishishirakawa-gun

080-0013

Research Site, Obihiro-shi

503-8502

Research Site, Ogaki-shi

904-2143

Research Site, Okinawa-shi

831-0016

Research Site, Ookawa-shi

543-0035

Research Site, Osaka

589-8511

Research Site, Osakasayama-shi

870-0921

Research Site, Ōita

870-0951

Research Site, Ōita

520-0804

Research Site, Ōtsu

762-8550

Research Site, Sakaide-shi

591-8555

Research Site, Sakaishi

001-0901

Research Site, Sapporo

064-0915

Research Site, Sapporo

980-8574

Research Site, Sendai

983-0824

Research Site, Sendai

984-8560

Research Site, Sendai

489-8642

Research Site, Seto-shi

142-8666

Research Site, Shinagawa-ku

162-0052

Research Site, Shinjuku-ku

420-8630

Research Site, Shizuoka

564-0013

Research Site, Suita-shi

190-0014

Research Site, Tachikawa-shi

760-8538

Research Site, Takamatsu

791-0281

Research Site, Toon-shi

171-0014

Research Site, Toshima-ku

930-0194

Research Site, Toyama

931-8533

Research Site, Toyama

939-8282

Research Site, Toyama

832-0059

Research Site, Yanagawa-shi

236-0004

Research Site, Yokohama

Sponsors
All Listed Sponsors
lead

Pearl Therapeutics, Inc.

INDUSTRY